Literature DB >> 25020013

Reducing risks in type 1 diabetes using H∞ control.

Patricio Colmegna, Ricardo S Sanchez Pena, Ravi Gondhalekar, Eyal Dassau, Francis J Doyle Iii.   

Abstract

A control scheme was designed in order to reduce the risks of hyperglycemia and hypoglycemia in type 1 diabetes mellitus (T1DM). This structure is composed of three main components: an H∞ robust controller, an insulin feedback loop (IFL), and a safety mechanism (SM). A control-relevant model that is employed to design the robust controller is identified. The identification procedure is based on the distribution version of the UVA/Padova metabolic simulator using the simulation adult cohort. The SM prevents dangerous scenarios by acting upon a prediction of future glucose levels, and the IFL modifies the loop gain in order to reduce postprandial hypoglycemia risks. The procedure is tested on the complete alic>in silico adult cohort of the UVA/Padova metabolic simulator, which has been accepted by the Food and Drug Administration (FDA) in lieu of animal trials.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25020013     DOI: 10.1109/TBME.2014.2336772

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  9 in total

1.  Periodic zone-MPC with asymmetric costs for outpatient-ready safety of an artificial pancreas to treat type 1 diabetes.

Authors:  Ravi Gondhalekar; Eyal Dassau; Francis J Doyle
Journal:  Automatica (Oxf)       Date:  2016-06-01       Impact factor: 5.944

2.  Reducing Glucose Variability Due to Meals and Postprandial Exercise in T1DM Using Switched LPV Control: In Silico Studies.

Authors:  Patricio H Colmegna; Ricardo S Sánchez-Peña; Ravi Gondhalekar; Eyal Dassau; Francis J Doyle
Journal:  J Diabetes Sci Technol       Date:  2016-05-03

3.  Switched LPV Glucose Control in Type 1 Diabetes.

Authors:  Patricio H Colmegna; Ricardo S Sanchez-Pena; Ravi Gondhalekar; Eyal Dassau; Frank J Doyle
Journal:  IEEE Trans Biomed Eng       Date:  2015-10-05       Impact factor: 4.538

4.  Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses.

Authors:  Ricardo Sánchez-Peña; Patricio Colmegna; Fabricio Garelli; Hernán De Battista; Demián García-Violini; Marcela Moscoso-Vásquez; Nicolás Rosales; Emilia Fushimi; Enrique Campos-Náñez; Marc Breton; Valeria Beruto; Paula Scibona; Cintia Rodriguez; Javier Giunta; Ventura Simonovich; Waldo H Belloso; Daniel Cherñavvsky; Luis Grosembacher
Journal:  J Diabetes Sci Technol       Date:  2018-07-12

5.  Blood glucose concentration control for type 1 diabetic patients: a multiple-model strategy.

Authors:  Yazdan Batmani; Shadi Khodakaramzadeh
Journal:  IET Syst Biol       Date:  2020-02       Impact factor: 1.615

6.  Chattering-free hybrid adaptive neuro-fuzzy inference system-particle swarm optimisation data fusion-based BG-level control.

Authors:  Ali Karsaz
Journal:  IET Syst Biol       Date:  2020-02       Impact factor: 1.615

7.  Adaptive fractional-order blood glucose regulator based on high-order sliding mode observer.

Authors:  Hadi Delavari; Hamid Heydarinejad; Dumitru Baleanu
Journal:  IET Syst Biol       Date:  2019-04       Impact factor: 1.615

8.  Robust multi-objective blood glucose control in Type-1 diabetic patient.

Authors:  Sharmistha Mandal; Ashoke Sutradhar
Journal:  IET Syst Biol       Date:  2019-06       Impact factor: 1.615

9.  Towards the Integration of an Islet-Based Biosensor in Closed-Loop Therapies for Patients With Type 1 Diabetes.

Authors:  Loïc Olçomendy; Louis Cassany; Antoine Pirog; Roberto Franco; Emilie Puginier; Manon Jaffredo; David Gucik-Derigny; Héctor Ríos; Alejandra Ferreira de Loza; Julien Gaitan; Matthieu Raoux; Yannick Bornat; Bogdan Catargi; Jochen Lang; David Henry; Sylvie Renaud; Jérôme Cieslak
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-22       Impact factor: 6.055

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.